Clinical Research Support Services (CRSS) support clinical investigations in the development and implementation of clinical trials at Moffitt Cancer Center by: 1) Supporting clinical investigators in screening and enrolling patients onto clinical trials; 2) Providing Data Management support for clinical trials; 3) Providing staff training and education pertaining to clinical trials; 4) Coordinating and implementing protocolrelated orders for study patients; and 5) Preparing medical records for audits. CRSS provide data management support to 17 disease-specific divisions and Lifetime Cancer Screening and Prevention Center, the locus for cancer control and prevention studies/trials. The majority of these investigators are in the Experimental Therapeutics Program, while the remaining are in the Cancer Prevention & Control Program. The CRSS employs approximately 60 staff members to support 70 faculty. Protocol activation and implementation is coordinated via a partnership between the Protocol Review & Monitoring Systems/Scientific Review Committees (PRMS/SRC) and CRSS staff. CRSS staff work with investigators to: acquire the protocol and investigator brochure (if appropriate), complete process flow paperwork, and acquire appropriate institutional signatures prior to PRMS/SRC submission. CRSS staff acts as a liaison between the sponsor and institution to provide relevant information to both parties. Staff work closely with a clinical trials specialist in the sponsored research division to help create the study budget and provide feedback as to standard vs. non-standard of care charges. All clinical research protocols that accrue patients or utilize patient tissue/blood/bone marrow require operational review. CRSS are responsible for ensuring eligible patients are enrolled onto approved clinical trials. CRSS utilizes Clinical Trials Coordinators to: actively screen and evaluate new patients as potential study candidates, coordinate patient enrollment, and work with investigators and patients during informed consent. Data management is available for investigatorinitiated, cooperative group and industry-sponsored trials. Data collection, transcription and submission are the responsibility of the clinical trials coordinator assigned to the clinical division. Since few protocols use computer data entry/remote data retrieval, most studies require data transcription and hard copy submission. Clinical coordinators are instrumental in developing appropriate and adequate data collection tools. CRSS staff are responsible for tracking the required forms for active trials in their corresponding programs. Oncore? clinical trials management system is a comprehensive solution for managing all aspects of clinical research. Oncore? enables the staff to track all protocols from initial scientific review through IRB approval and activation, and provides data for ongoing monitoring until final closure. The system is currently being installed at the Cancer Center and will be live within several months

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA076292-10
Application #
7579082
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2008-02-01
Budget End
2009-01-31
Support Year
10
Fiscal Year
2008
Total Cost
$219,482
Indirect Cost
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Persi, Erez; Duran-Frigola, Miquel; Damaghi, Mehdi et al. (2018) Systems analysis of intracellular pH vulnerabilities for cancer therapy. Nat Commun 9:2997
Kim, Youngchul; Pierce, Christine M; Robinson, Lary A (2018) Impact of viral presence in tumor on gene expression in non-small cell lung cancer. BMC Cancer 18:843
Chen, Yan; Zhu, Jin-Yi; Hong, Kwon Ho et al. (2018) Structural Basis of ALDH1A2 Inhibition by Irreversible and Reversible Small Molecule Inhibitors. ACS Chem Biol 13:582-590
Rosenberger, Albert; Hung, Rayjean J; Christiani, David C et al. (2018) Genetic modifiers of radon-induced lung cancer risk: a genome-wide interaction study in former uranium miners. Int Arch Occup Environ Health 91:937-950
Kahen, Elliot John; Brohl, Andrew; Yu, Diana et al. (2018) Neurofibromin level directs RAS pathway signaling and mediates sensitivity to targeted agents in malignant peripheral nerve sheath tumors. Oncotarget 9:22571-22585
Hoffman, Melissa A; Fang, Bin; Haura, Eric B et al. (2018) Comparison of Quantitative Mass Spectrometry Platforms for Monitoring Kinase ATP Probe Uptake in Lung Cancer. J Proteome Res 17:63-75
Puri, Sonam; Hyland, Kelly A; Weiss, Kristine Crowe et al. (2018) Prediction of chemotherapy-induced nausea and vomiting from patient-reported and genetic risk factors. Support Care Cancer 26:2911-2918
Gonzalez, Brian D; Small, Brent J; Cases, Mallory G et al. (2018) Sleep disturbance in men receiving androgen deprivation therapy for prostate cancer: The role of hot flashes and nocturia. Cancer 124:499-506
Eroglu, Zeynep; Zaretsky, Jesse M; Hu-Lieskovan, Siwen et al. (2018) High response rate to PD-1 blockade in desmoplastic melanomas. Nature 553:347-350
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430

Showing the most recent 10 out of 1254 publications